Biological activity of retinoids correlates with affinity for nuclear receptors but not for cytosolic binding protein.
In order to better understand the respective roles of the nuclear retinoic acid receptors (RARs) and the cytosolic retinoic acid binding protein (CRABP) in the mode of action of retinoic acid (RA), several types of RA analogs have been synthesized. Representative compounds have been radiolabeled to a high specific activity and their binding (direct and competition) to RARs and CRABP was determined. Their biological activity on F9 embryonal carcinoma cell differentiation has been determined by a quantitative assay of plasminogen activator (PA). All biologically active analogs studied in this work bound to RARs. A good correlation was found between PA induction and affinity for the RARs, with the exception of RA itself which was a good ligand but a moderate inducer of F9 differentiation. Two biologically active analogs (compounds II and III) did not bind to the CRABP. One biologically inactive analog (compound VIII) bound to CRABP. These results strongly suggest that retinoids must bind to RARs but not necessarily to CRABP in order to induce cell differentiation in F9 cells.
Darmon
M
M
Centre International de Recherches Dermatologiques, Sophia Antipolis, Valbonne, France.
Rocher
M
M
Cavey
M T
MT
Martin
B
B
Rabilloud
T
T
Delescluse
C
C
Shroot
B
B
D000818:Animals; D002352:Carrier Proteins / Q000378:metabolism* / Q000502:physiology; D002467:Cell Nucleus / Q000378:metabolism*; D003600:Cytosol / Q000378:metabolism*; D007700:Kinetics; D051379:Mice; D008970:Molecular Weight; D011485:Protein Binding; D051381:Rats; D018168:Receptors, Retinoic Acid; D012176:Retinoids / Q000138:chemical synthesis / Q000378:metabolism / Q000494:pharmacology*; D014407:Tumor Cells, Cultured / Q000187:drug effects / Q000378:metabolism
D002352:Carrier Proteins; D018168:Receptors, Retinoic Acid; D012176:Retinoids